Abstract: A method for reading slides bearing fluorescent deposits, such as used in serology or molecular biology analysis, includes: incubating a slide with a sample of serum from a patient, or a dilution thereof, and revealing antibodies in the sample bound to the deposits by labelled reagents. Label reading and analysis is performed by a device including a slide positioner, light emitting diodes arranged in illumination channels to provide oblique illumination at different wave lengths, and a collection optic for forming an image of the deposits on a sensor.

Abstract: A method for the serological diagnosis, in vitro, of an infection with a spirochete bacterium which is pathogenic in humans, chosen from bacteria of the Borrelia, Leptospira and Treponema genera, by carrying out at least one of 1) an assay of IgG-type and/or IgM-type antibodies against at least one tick-borne Borrelia bacterium, chosen from Borrelia duttonii and Borrelia crocidurae, and 2) an assay of IgM-type antibodies against the louse-borne Borrelia bacterium Borrelia recurrentis.

Abstract: This application relates to an incubation device for serology or histology supports. It also relates to any apparatus comprising one such device, and to the use of said apparatuses and/or devices in analysis or diagnosis methods.

Abstract: The invention concerns a device for reading slides bearing fluorescent deposits, such as used in serology or molecular biology analysis. The invention also concerns any apparatus comprising such a device, specific implementing software, as well as the use of said apparatuses and/or devices in analytical or diagnostic methods.

Abstract: The present invention concerns a method for determining vaccine status by quantifying type-IgG serum antibodies of a plurality of pathogenic agents, characterized in that the steps are conducted of: 1—contacting one same said serum sample to be tested with one same solid substrate on which a plurality of said vaccine antigens is fixed corresponding to a plurality of vaccine antigens of different pathogenic agents, at different areas of the substrate, in the presence of at least one detection substance reacting by complexing with said IgG-type specific antibodies and not reacting with said vaccine antigens, and 2—the concentration of said IgG-type specific antibodies is determined.